Jo Anne Zujewski, MD is the Head - Breast Cancer Therapeutics, in the Clinical Investigation Branch of the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute. In this role, she is the scientific liaison and disease expert for breast cancer clinical trials sponsored by the CTEP program of the NCI.
Dr. Zujewski’s research activities include the clinical development of targeted agents for the treatment of breast cancer. She was the founding chairperson of the Breast Cancer Faculty steering committee at NCI and a member of the planning committee for the NIH Consensus conference for the adjuvant treatment of breast cancer, Preoperative Therapy in Invasive Breast Cancer scheduled, and the state of the science meeting for Ductal Carcinoma in situ. She has an interest in global breast health and has served as an expert medical consultant to several international initiatives in breast cancer. She is the author of numerous publications in breast cancer treatment and prevention.
A native of Chicago, Illinois, she received her Bachelor of Science in Medical Technology from Marquette University and her Masters of Administrative Science from Johns Hopkins Evening College. Dr. Zujewski earned her M.D. at the University of Minnesota. She completed her internal medicine residency at University of Washington and her medical oncology fellowship at the University of Washington and Fred Hutchinson Cancer Research Center. Dr. Zujewski joined the staff at the National Cancer Institute in 1993. She spent her first 10 years at the NCI in the intramural research program evaluating targeted therapeutics for the prevention and treatment of breast cancer. In November, 2004, Dr. Zujewski joined the Cancer Therapy Evaluation Program (CTEP) as the Head - Breast Cancer Therapeutics of the Clinical Investigations Branch.
National Cancer Institute
6130 Executive Blvd., Suite 7025
Bethesda, MD 20892-7436